January 2024
1. HOELZER D, Bassan R, Boissel N, Roddie C, et al
   ESMO Clinical Practice Guideline interim update on the use of targeted therapy in acute lymphoblastic leukaemia.
   Ann Oncol. 2024;35:15-28.
   

   >> Share

   
   July 2023
2. CASS SH, Tobin JWD, Seo YD, Gener-Ricos G, et al
   Efficacy of Immune Checkpoint Inhibitors for the Treatment of Advanced Melanoma in Patients with Concomitant Chronic Lymphocytic Leukemia.
   Ann Oncol. 2023 Jul 4:S0923-7534(23)00735-4. doi: 10.1016/j.annonc.2023.
   

   >> Share

   
   January 2023
3. MALVEZZI M, Santucci C, Boffetta P, Collatuzzo G, et al
   EUROPEAN CANCER MORTALITY PREDICTIONS FOR THE YEAR 2023 WITH FOCUS ON LUNG CANCER.
   Ann Oncol. 2023 Jan 27:S0923-7534(23)00048-0. doi: 10.1016/j.annonc.2023.
   

   >> Share

   
   November 2022
4. BAZINET A, Kantarjian HM
   Moving towards individualized target-based therapies in acute myeloid leukemia.
   Ann Oncol. 2022 Nov 21:S0923-7534(22)04734-2. doi: 10.1016/j.annonc.2022.
   

   >> Share

   
   April 2022
5. GEYER CE, Sikov WM, Loibl S
   Reply to the Letter to the Editor "Risk of MDS/AML with the addition of neoadjuvant carboplatin to standard chemotherapy for triple negative breast cancer" by A. Okines and N. Turner.
   Ann Oncol. 2022 Apr 4. pii: S0923-7534(22)00671.
   

   >> Share

   
   March 2022
6. OKINES A, Turner N
   Risk of MDS/AML with the addition of neoadjuvant carboplatin to standard chemotherapy for triple negative breast cancer.
   Ann Oncol. 2022 Mar 14. pii: S0923-7534(22)00364.
   

   >> Share

   
   November 2021
7. VAN GELDER M, Tournilhac O, Te Raa D, Visser HPJ, et al
   Front-line chemo-immunotherapy is not inferior to ibrutinib in CLL.
   Ann Oncol. 2021;32:1442-1443.
   

   >> Share

   
   August 2021
8. LORIOT Y, Marabelle A, Guegan JP, Danlos FX, et al
   Plasma proteomics identifies Leukemia Inhibitory Factor (LIF) as a novel predictive biomarker of immune-checkpoint blockade resistance.
   Ann Oncol. 2021 Aug 17. pii: S0923-7534(21)03978.
   

   >> Share

   
   May 2021
9. DONNETTE M, Ciccolini J, Pissier C, Costello R, et al
   High incidence of CDA deficiency in patients with hematological malignancies: perspectives and therapeutic implications.
   Ann Oncol. 2021;32:684-686.
   

   >> Share

   
   

Free Medical Abstracts
Privacy Policy
Sponsors
Share